EMEA-000995-PIP01-10 - paediatric investigation plan

iloperidone
PIPHuman

Key facts

Active substance
iloperidone
Therapeutic area
Psychiatry
Decision number
P/71/2011
PIP number
EMEA-000995-PIP01-10
Pharmaceutical form(s)
  • Suspension for injection
  • Tablet
Condition(s) / indication(s)
Treatment of schizophrenia
Route(s) of administration
  • Intramuscular use
  • Oral use
Contact for public enquiries

Vanda Pharmaceuticals Ltd

United States
E-mail: gunther.birznieks@vandapharma.com
Tel. +1 202 7343416
Fax +1 202 2961450

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Compliance check done
No

Decision

Share this page